Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963500 | Vaccine | 2015 | 8 Pages |
Abstract
Two doses of 4CMenB had an acceptable safety profile and induced a robust immune response in adolescents. Peak antibody responses were observed at 14 days following vaccination. While a substantial non-uniform antigen-dependent early decline in antibody titers was seen thereafter, a significant percentage of participants continued to maintain protective hSBA titers at 1-month.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kirsten P. Perrett, Jodie McVernon, Peter C. Richmond, Helen Marshall, Michael Nissen, Allison August, Sandra Percell, Daniela Toneatto, Terry Nolan,